home / stock / bngo / bngo news

BNGO News and Press, Bionano Genomics Inc. From 01/13/22

Stock Information
Company Name: Bionano Genomics Inc.
Stock Symbol: BNGO
Market: NASDAQ
Website: bionanogenomics.com
Menu
BNGO BNGO Quote BNGO Short BNGO News BNGO Articles BNGO Message Board
Get BNGO Alerts

News, Short Squeeze, Breakout and More Instantly...
BNGO - Bionano Genomics Hosts Final Day of 2022 Symposium with Presentations Demonstrating the Combined Detection Power of OGM and NGS

SAN DIEGO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr ® system and provider of N x Clinical™, the leading software solutions for visualization, interpretation and reporting of genomic d...
BNGO - Bionano Genomics Hosts Day 3 of 2022 Symposium with New Research Demonstrating Applications of OGM in Solid Tumor Analysis

SAN DIEGO, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr ® system and provider of N x Clinical™, the leading software solutions for visualization, interpretation and reporting of genomic d...

BNGO - Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2021 Results

- Preliminary Q4 revenue expected between $5.8 and $6.2 million; 45%-55% increase over Q4 2020 - Reached installed base of 164 systems: 69% increase over YE 2020 - Achieved or exceeded all stated goals and milestones for the full year 2021 SAN DIEGO, Jan. 12, 202...

BNGO - Bionano Genomics Hosts Day 2 of 2022 Symposium with New Research Demonstrating How OGM Detects Known and Novel Variants in Hematologic Malignancies

SAN DIEGO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr ® system and provider of N x Clinical™, the leading software solutions for visualization, interpretation and reporting of genomic d...
BNGO - UPDATE - Bionano Genomics Hosts Day 1 of 2022 Symposium with Six Presentations Highlighting the Superior Performance of OGM in Variant Detection for Constitutional Genetic Diseases

SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr ® system and provider of N x Clinical™, the leading software solutions for visualization, interpretation and reporting of genomic d...

BNGO - Bionano Genomics Hosts Day 1 of 2022 Symposium with Six Presentations Highlighting the Superior Performance of OGM in Variant Detection for Constitutional Genetic Diseases

SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr ® system and provider of N x Clinical™, the leading software solutions for visualization, interpretation and reporting of genomic d...

BNGO - Bionano Genomics Announces Publication of Interim Readout from the Consortium Conducting a Postnatal Clinical Trial Intended to Support Establishing Optical Genome Mapping as Part of Standard of Care in Genetic Disease Diagnosis

IRB-approved, multi-site, ongoing study evaluated 331 individual sample runs from 202 unique samples across 5 sites for interim measures of key endpoints: Concordance with standard of care (SOC) – 97.7% [214 out of 219 samples] Partially concordant with SOC ...
BNGO - Bionano Genomics Announces the Final Speaker Lineup for 2022 Symposium

– 27 different customers representing North America and Europe – 31 oral presentations across four consecutive days – Topics span the application of OGM in genetic disease and cancer research – 45% of presentations are from North Ame...

BNGO - Bionano Genomics Stock Is a Low-Priced Bet on Sound Science

InvestorPlace - Stock Market News, Stock Advice & Trading Tips For folks with a tolerance for risk, life sciences company Bionano Genomics (NASDAQ: BNGO ) is definitely worth a look. It takes guts to invest in out-of-favor assets like BNGO stock, but the long-term rewards could b...

BNGO - Bionano up 3% premarket following prototype of optical genome mapping system

Shares of Bionano Genomics (NASDAQ:BNGO) are up 3% premarket after announcing a prototype of a new single molecule imaging system for optical genome mapping ("OGM"). The company says the system is capable of providing the most comprehensive, reliable, and cost-effective solution for detecting...
Previous 10 Next 10